| iQone Healthcare Switzerland SA - Yuflyma 40 mg, solution injectable en stylo prérempli |
| 68515 | | 01 | | Yuflyma 40 mg | | solution injectable en stylo prérempli | | L04AB04 | | Adalimumab | | 22.06.2022 | | |
|
| Composition |
| adalimumabum 40 mg, acidum aceticum, natrii acetas trihydricus corresp. natrium 0.07 mg, glycinum, polysorbatum 80, aqua ad iniectabile ad solutionem pro 0.4 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Adalimumab | 40mg / 0.4ml |
| | BAG: Active Agent | Dose |
|---|
| Adalimumab | 40 mg |
| | | | Inactive agents |
|---|
| Acetic Acid | | Glycin | | Sodium Acetate Trihydrate | | Polysorbatum 80 |
| |
|
|
